Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Splenomegaly is an enlarged spleen. Your spleen is an organ in your upper left abdomen, tucked under your rib cage. It's an important part of your lymphatic system and plays a role in immunity.

GSK announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult patients with intermediate or high-risk primary ...

From the Medical Service of the Beth Israel Hospital. Fried — Assistant in Medicine, Beth Israel Hospital. For record and address of author see "This Week's Issue." page 632. Select the format ...

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

GSK’s $1.9 billion takeover of Sierra Oncology has delivered the first new product, with the EU approval of Omjjara for the treatment of enlarged spleen (splenomegaly) or symptoms in adult ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Esan pipo dey call dia tattoos Ema Udeh – body markings wey dem dey use as treatment for splenomegaly or swollen spleen.

Simvastatin could be an effective therapy for portal hypertension, according to a study by Abraldes and colleagues, which shows that the drug decreases portal hypertension and improves liver ...

Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the ...

Splenomegaly resulting from portal hypertension can be caused by cirrhosis, hepatic venous outflow tract obstruction and extrahepatic portal vein obstruction. Both cirrhosis and hepatic venous ...